Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 13,374 | 8,213 | 42,469 | 10,789 | 9,626 |
| Gross Profit | 13,374 | 8,213 | 42,469 | 10,789 | 9,626 |
| Operating Expenses | 19,718 | 19,583 | 22,670 | 21,672 | 20,719 |
| Operating Income | -6,344 | -11,370 | 19,799 | -10,883 | -11,093 |
| Interest Expense | -2,487 | 0 | 0 | 0 | -895 |
| Other Income | 0 | 2,291 | 2,291 | 1,687 | 0 |
| Pre-tax Income | -3,857 | -9,079 | 22,090 | -9,196 | -10,198 |
| Net Income Continuous | -3,857 | -9,079 | 22,090 | -9,196 | -10,198 |
| Net Income | $-3,857 | $-9,079 | $22,090 | $-9,196 | $-10,198 |
| EPS Basic Total Ops | -0.20 | -0.54 | 2.67 | -0.72 | -1.33 |
| EPS Basic Continuous Ops | -0.20 | -0.54 | 2.69 | -0.72 | -1.33 |
| EPS Diluted Total Ops | -0.20 | -0.54 | 2.67 | -0.72 | -1.33 |
| EPS Diluted Continuous Ops | -0.20 | -0.54 | 2.69 | -0.72 | -1.33 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.54 | 2.48 | -0.72 | -1.33 |
| EBITDA(a) | $-7,092 | $-12,133 | $19,003 | $-11,482 | $-11,440 |